Intrinsic Value of S&P & Nasdaq Contact Us

Crescent Biopharma, Inc. CBIO NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$33.00
+65.4%

Crescent Biopharma, Inc. (CBIO) has 5 identified peers for comparison in the Healthcare sector. Peers include AKTX, BLPH, BNTC, HTGM, PULM.

CBIO has a market capitalization of $549.76M, compared to an average peer market cap of $73.4M. CBIO is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message